> 0 1 0 1 O
18 1 3 1 3 B-lower_bound
years 4 9 4 9 I-lower_bound
of 10 12 10 12 O
age 13 16 13 16 B-age

Anticipated 0 11 17 28 O
replacement 12 23 29 40 O
of 24 26 41 43 O
central 27 34 44 51 O
venous 35 41 52 58 O
catheter 42 50 59 67 O
within 51 57 68 74 O
3 58 59 75 76 B-upper_bound
months 60 66 77 83 I-upper_bound

Catheter 0 8 84 92 O
removal 9 16 93 100 O
> 17 18 101 102 O
1 18 19 102 103 B-lower_bound
month 20 25 104 109 I-lower_bound
prior 26 31 110 115 I-lower_bound
to 32 34 116 118 O
enrollment 35 45 119 129 O

Creatinine 0 10 130 140 B-clinical_variable
clearance 11 20 141 150 I-clinical_variable
> 21 22 151 152 O
30 22 24 152 154 B-lower_bound
ml 25 27 155 157 I-lower_bound
/ 27 28 157 158 I-lower_bound
min 28 31 158 161 I-lower_bound

Current 0 7 162 169 O
hematologic 8 19 170 181 B-chronic_disease

Known 0 5 182 187 O
underlying 6 16 188 198 O
higher 17 23 199 205 O
risk 24 28 206 210 O
thrombophilias 29 43 211 225 B-chronic_disease
including 44 53 226 235 O
antiphospholipid 54 70 236 252 B-chronic_disease
antibody 71 79 253 261 I-chronic_disease
syndrome 80 88 262 270 I-chronic_disease
, 88 89 270 271 O
antithrombin 90 102 272 284 O
, 102 103 284 285 O
protein 104 111 286 293 B-chronic_disease
C 112 113 294 295 I-chronic_disease
or 114 116 296 298 I-chronic_disease
protein 117 124 299 306 I-chronic_disease
S 125 126 307 308 I-chronic_disease
deficiencies 127 139 309 321 I-chronic_disease
, 139 140 321 322 O
or 141 143 323 325 O
homozygosity 144 156 326 338 O
or 157 159 339 341 O
compound 160 168 342 350 B-chronic_disease
heterozygosity 169 183 351 365 I-chronic_disease
for 184 187 366 369 O
prothrombin 188 199 370 381 B-chronic_disease
G20210A 200 207 382 389 I-chronic_disease
or 208 210 390 392 O
Factor 211 217 393 399 B-treatment
V 218 219 400 401 I-treatment
R506Q 220 225 402 407 I-treatment
mutations 226 235 408 417 O

Major 0 5 418 423 O
bleeding 6 14 424 432 O
or 15 17 433 435 O
clinically 18 28 436 446 O
relevant 29 37 447 455 O
non 38 41 456 459 O
- 41 42 459 460 O
major 42 47 460 465 O
bleeding 48 56 466 474 O
in 57 59 475 477 O
the 60 63 478 481 O
preceding 64 73 482 491 O
60 74 76 492 494 B-lower_bound
days 77 81 495 499 I-lower_bound

Participation 0 13 500 513 O
in 14 16 514 516 O
another 17 24 517 524 O
clinical 25 33 525 533 O
trial 34 39 534 539 O
that 40 44 540 544 O
requires 45 53 545 553 O
anticoagulation 54 69 554 569 B-treatment

Platelet 0 8 570 578 B-clinical_variable
count 9 14 579 584 I-clinical_variable
> 15 16 585 586 O
50,000 16 22 586 592 B-lower_bound

Treatment 0 9 593 602 O
with 10 14 603 607 O
thrombolysis 15 27 608 620 B-treatment

Underlying 0 10 621 631 O
medical 11 18 632 639 O
condition 19 28 640 649 O
or 29 31 650 652 O
chemotherapy 32 44 653 665 B-treatment
requiring 45 54 666 675 O
long 55 59 676 680 O
- 59 60 680 681 O
term 60 64 681 685 O
anticoagulation 65 80 686 701 B-treatment

Upper 0 5 702 707 O
extremity 6 15 708 717 O
venous 16 22 718 724 B-chronic_disease
thrombosis 23 33 725 735 I-chronic_disease
associated 34 44 736 746 O
with 45 49 747 751 O
an 50 52 752 754 O
indwelling 53 63 755 765 O
catheter 64 72 766 774 O
documented 73 83 775 785 O
by 84 86 786 788 O
ultrasound 87 97 789 799 B-treatment
, 97 98 799 800 O
CT 99 101 801 803 B-treatment
or 102 104 804 806 O
venography 105 115 807 817 B-treatment

Use 0 3 818 821 O
of 4 6 822 824 O
anticoagulant 7 20 825 838 B-treatment
other 21 26 839 844 O
than 27 31 845 849 O
low 32 35 850 853 B-treatment
- 35 36 853 854 I-treatment
molecular 36 45 854 863 I-treatment
weight 46 52 864 870 I-treatment
heparin 53 60 871 878 I-treatment

solid 0 5 879 884 B-cancer
tumor 6 11 885 890 I-cancer
malignancy 12 22 891 901 I-cancer
undergoing 23 33 902 912 O
chemotherapy 34 46 913 925 B-treatment
, 46 47 925 926 O
surgery 48 55 927 934 B-treatment
, 55 56 934 935 O
radiation 57 66 936 945 B-treatment
or 67 69 946 948 O
hormonal 70 78 949 957 B-treatment
therapy 79 86 958 965 I-treatment
for 87 90 966 969 O
malignancy 91 101 970 980 O

